Navigation Links
US Oncology Wins Three National Safety Council Awards

Texas Chapter Recognizes Pharmaceutical Distribution Center, Specialty Pharmacy and Research Network

HOUSTON, March 30 /PRNewswire/ -- Three US Oncology, Inc. businesses have received a Safety Excellence Perfect Record Award in the Occupational Safety & Health category from the Texas chapter of the National Safety Council: US Oncology Research, OncologyRx Care Advantage(TM), and US Oncology Specialty, LP. This is the third time US Oncology companies have received the Occupational Excellence Award from the national organization's Texas chapter. More information can be found at

The award is presented to companies, units and/or facilities that have completed a period of at least 12 consecutive months without incurring an occupational injury or illness that resulted in days away from work or death.

From 2007 to 2008, US Oncology Specialty, OncologyRx Care Advantage, and US Oncology Research each achieved a zero percent incidence rate for number of days away from work. Following are the 2008 statistics for each:

  • US Oncology Specialty, LP - 34 employees who worked 63,628 hours
  • OncologyRx Care Advantage--25 employees working 47,765 hours
  • US Oncology Research Network--16 employees who worked 29,989 hours

Formed in 1999, US Oncology collaborates with providers, payers, biotechnology, pharmaceutical and medical equipment manufacturers to increase patient access to advanced cancer care. US Oncology supports one of the nation's foremost cancer treatment and research networks, accelerating the availability and use of evidence-based medicine and shared best practices.

US Oncology Specialty, LP, is US Oncology's VAWD(TM) certified drug distribution center focused on delivering safe and effective oncology drugs to community-based practices. Its ePedigree technology tracks all products from manufacturer to the practice, and back again in case of returns.

OncologyRx Care Advantage, a national oral oncology specialty pharmacy, provides patients with convenient home delivery of oral cancer therapies and the additional support necessary for safe and supervised use of these oral therapy treatments. Last year the specialty pharmacy successfully expanded to a national service offering, bringing access to home delivery of oral drugs and critical patient support to cancer patients in all 50 U.S. states and the territory of Puerto Rico.

The US Oncology Research network is an established community-based research operation specializing in comprehensive Phase I-IV trials and translational Phase I research. Supported by US Oncology, the network has played a pivotal role in 35 cancer therapies approved by the Food and Drug Administration and more than 38,500 patients have participated in clinical trials.

About US Oncology

US Oncology, headquartered in the Houston area, works closely with physicians, payers, biotechnology, pharmaceutical and medical equipment manufacturers to identify and deliver innovative services that enhance patient access to advanced cancer care.

US Oncology uses its expertise to support every aspect of the cancer care delivery system--from drug development to distribution and outcomes measurement--enabling the company to help increase the efficiency and safety of cancer care. According to the company's last quarterly earnings report, US Oncology is affiliated with 1,211 physicians operating in 456 locations, including 94 radiation oncology facilities in 39 states. For more information, visit the company's Web site,

About the National Safety Council

The National Safety Council is a nonprofit, nongovernmental, international public service organization dedicated to protecting life and promoting health. Members of NSC include more than 45,000 businesses, labor organizations, schools, public agencies, private groups and individuals. Founded in 1913, and chartered by the U.S. Congress in 1953, the primary focus of the NSC is preventing injuries in workplaces, in transportation and in homes and communities.

SOURCE US Oncology, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Genomic Health Announces Multiple Studies on Oncotype DX(TM) Presented at 2007 American Society of Clinical Oncology (ASCO) Breast Cancer Symposium
2. ESMO, Oxford Journals and the Japanese Society of Medical Oncology announce collaboration
3. SuperGen to Highlight Oncology Pipeline Data in Multiple Presentations at the AACR-NCI-EORTC International Conference
4. U.S. Oncology Initiates Complete Phase Ib Trial of Brostallicin Combination Therapy in Advanced Solid Tumors
5. US Oncology to Report 2007 Third Quarter Earnings Results
6. VioQuest to Present Data on Oncology Compounds VQD-002 and Lenocta(TM) at AACR-NCI-EORTC International Meeting
7. Genomic Health Reports Inclusion of Oncotype DX(TM) in American Society of Clinical Oncology Guidelines
8. Varian Medical Systems Ranks First in Overall Service Performance in 2007 Survey of U.S. Radiation Oncology Professionals
9. Accuray Announces Four New Products at Nations Leading Radiation Oncology Meeting
10. Debiopharm and NanoCarrier Sign License and Supply Agreement for Dach-Platin Polymeric Micelle in Oncology
11. National Autism Association and Deirdre Imus Environmental Center for Pediatric Oncology Announce National Greening Your School Initiative
Post Your Comments:
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... Yisrayl Hawkins, ... week that explains one of the most popular and least understood books in the ... cryptic and puzzling descriptions that have baffled scholars for centuries. Many have tossed it ...
(Date:10/12/2017)... ... October 12, 2017 , ... First Healthcare Compliance ... management, will showcase a range of technology and learning solutions at the 68th ... and Expo to be held October 14–18, 2017 at the Mandalay Bay Resort ...
(Date:10/12/2017)... ... October 12, 2017 , ... The American College of Medical Informatics ... PhD, FACMI, during the Opening Session of AMIA’s Annual Symposium in Washington, D.C. AMIA’s ... of Morris F. Collen, a pioneer in the field of medical informatics, this prestigious ...
(Date:10/12/2017)... D.C. (PRWEB) , ... October 12, 2017 , ... Leading ... their peers in Washington, D.C., for the 49th Congress of the International Society ... ., Vice President of the Center for Cancer and Blood Disorders at ...
(Date:10/12/2017)... , ... October 12, 2017 , ... ... latest in wound care advancements to physician colleagues, skilled nursing facility medical directors ... "Navigating the Treacherous Waters of Wound Care." , "At many of these conferences ...
Breaking Medicine News(10 mins):
(Date:10/12/2017)... 12, 2017 AVACEN Medical , Inc. (AVACEN) ... their  2017 New Product Innovation Award for Its fibromyalgia ... and secondary medical device market research by Frost & Sullivan,s ... OTC, drug-free pain relief product, the AVACEN 100, offers a ... fibromyalgia widespread pain. ...
(Date:10/11/2017)... Oct. 11, 2017  Caris Life Sciences ® , ... the promise of precision medicine, today announced that St. ... Precision Oncology Alliance™ (POA) as its 17 th ... St. Jude Crosson Cancer Institute will help develop standards ... of tumor profiling, making cancer treatment more precise and ...
(Date:10/10/2017)... , Oct. 10, 2017   West Pharmaceutical ... innovative solutions for injectable drug administration, today shared the ... ID Adapter for improving the intradermal administration of polio ... Skin Vaccination Summit in May 2017 by Dr. ... Polio Department, World Health Organization (WHO), and recently published ...
Breaking Medicine Technology: